Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Health related quality of life after combined hormone replacement therapy: randomised controlled trial.

Welton AJ, Vickers MR, Kim J, Ford D, Lawton BA, MacLennan AH, Meredith SK, Martin J, Meade TW; WISDOM team.

BMJ. 2008 Aug 21;337:a1190. doi: 10.1136/bmj.a1190.

2.

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW; WISDOM group.

BMJ. 2007 Aug 4;335(7613):239. Epub 2007 Jul 11.

3.

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.

Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR; Women's Health Initiative Investigators.

Obstet Gynecol. 2005 May;105(5 Pt 1):1063-73.

PMID:
15863546
4.

The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.

Kwee SH, Tan HH, Marsman A, Wauters C.

Maturitas. 2007 Sep 20;58(1):83-90. Epub 2007 Aug 8.

PMID:
17689896
5.

A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life.

Voss S, Quail D, Dawson A, Bäckström T, Aguas F, Erenus M, The HS, Bonnar J, De Geyter C, Hunter M, Nickelsen T; Euralox Investigators Group.

BJOG. 2002 Aug;109(8):874-85.

6.

Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.

Pitkin J, Smetnik VP, Vadász P, Mustonen M, Salminen K, Ylikangas S; Indivina 321 Study Group.

Menopause Int. 2007 Sep;13(3):116-23.

PMID:
17785037
7.

The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial.

Veerus P, Hovi SL, Sevón T, Hunter M, Hemminki E.

BMC Res Notes. 2012 Apr 3;5:176. doi: 10.1186/1756-0500-5-176.

8.

A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.

Gast MJ, Freedman MA, Vieweg AJ, De Melo NR, Girão MJ, Zinaman MJ; Dyspareunia Study Group.

Menopause. 2009 Mar-Apr;16(2):247-56. doi: 10.1097/gme.0b013e318184c440.

PMID:
19034054
9.

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.

Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA; Heart and Estrogen/Progestin Replacement Study (HERS) Research Group.

JAMA. 2002 Feb 6;287(5):591-7.

PMID:
11829697
10.

A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.

Hilditch JR, Lewis J, Ross AH, Peter A, van Maris B, Franssen E, Charles J, Norton P, Dunn EV.

Maturitas. 1996 Jul;24(3):177-84.

PMID:
8844631
11.

Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.

Levine DW, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA.

Psychosom Med. 2005 Jan-Feb;67(1):98-104.

PMID:
15673630
12.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
13.

Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study.

Dias RS, Kerr-Corrêa F, Moreno RA, Trinca LA, Pontes A, Halbe HW, Gianfaldoni A, Dalben IS.

Menopause. 2006 Mar-Apr;13(2):202-11.

PMID:
16645534
14.

Effects of estrogen plus progestin on health-related quality of life.

Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG; Women's Health Initiative Investigators.

N Engl J Med. 2003 May 8;348(19):1839-54. Epub 2003 Mar 17.

15.

Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.

Polisseni AF, Andrade AT, Ribeiro LC, Castro IQ, Brandão M, Polisseni F, Guerra Mde O.

Maturitas. 2013 Feb;74(2):172-8. doi: 10.1016/j.maturitas.2012.11.001. Epub 2012 Nov 30.

PMID:
23201326
17.

A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Merz CN, Olson MB, McClure C, Yang YC, Symons J, Sopko G, Kelsey SF, Handberg E, Johnson BD, Cooper-DeHoff RM, Sharaf B, Rogers WJ, Pepine CJ.

Am Heart J. 2010 Jun;159(6):987.e1-7. doi: 10.1016/j.ahj.2010.03.024.

18.

Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.

Brunner RL, Aragaki A, Barnabei V, Cochrane BB, Gass M, Hendrix S, Lane D, Ockene J, Woods NF, Yasmeen S, Stefanick M.

Menopause. 2010 Sep-Oct;17(5):946-54. doi: 10.1097/gme.0b013e3181d76953.

19.

Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy.

Savolainen-Peltonen H, Hautamäki H, Tuomikoski P, Ylikorkala O, Mikkola TS.

Menopause. 2014 Jul;21(7):732-9. doi: 10.1097/GME.0000000000000120.

PMID:
24219882
20.
Items per page

Supplemental Content

Write to the Help Desk